Award recordCONTRACT

EXELAN PHARMACEUTICALS INC

PIID 36E79726D0021· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2026· $0 net obligations· UEI FYZXNHSQTMG8· FL

Description

MODIFICATION TO INCORPORATE SECTION 5 OF EXECUTIVE ORDER (EO) 14398.

Base award description: 3 LINE ITEMS FOR ZONISAMIDE CAPSULES. AWARD FOR A BASE YEAR OF 6/15/2026 - TO 6/14/2027 PLUS FOUR ONE-YEAR OPTION PERIODS.

First action · last action
2026-03-05 · 2026-09-01
Transactions
3
First transaction's obligation
$0
Base + all options value (sum of deltas)
$4,242,730
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2026-03-05 · this action $0 · running total $0Modification P00001 · 2026-03-28 · this action $0 · running total $0Modification P00002 · 2026-09-01 · this action $0 · running total $0
  • Base2026-03-05+$0= $0
  • Mod P000012026-03-28+$0= $0
  • Mod P000022026-09-01+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2026-03-05+$0$03 LINE ITEMS FOR ZONISAMIDE CAPSULES. AWARD FOR A BASE YEAR OF 6/15/2026 - TO 6/14/2027 PLUS FOUR ONE-YEAR OPT…
Mod P00001· ADD SUBCONTRACTING PLAN2026-03-28+$0$0INCORPORATE 2026/2027 SUBK PLAN
Mod P00002· OTHER ADMINISTRATIVE ACTION2026-09-01+$0$0MODIFICATION TO INCORPORATE SECTION 5 OF EXECUTIVE ORDER (EO) 14398.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FYZXNHSQTMG8)

AwardOffice · PSC / listingNet obligationsFY
36C24226N0564242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$5,337,256FY2026
36C25926F0197NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$1,844,059FY2026
36C26026F0261260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$918,831FY2026
36C26026F0169260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$712,808FY2026
36C24426N0400244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$1,487,248FY2026
36C24426N0397244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$1,007,003FY2026

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79726D0021_3600 · retrieved 2026-09-26.